25 Oct 2018 --- Lonza has reported ongoing momentum in the third quarter (Q3), boosted by its businesses along the healthcare continuum, including Pharma & Biotech and Speciality Ingredients. The company reports it is capitalizing on organic growth opportunities such as its Ibex solutions, which it recently expanded.
